Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Respiratory Disease Vaccines
Research from O. Ochoa-Gondar and co-authors reveals new findings on respiratory disease vaccines
May 28th, 2008
New investigation results, 'Effectiveness of pneumococcal vaccination in older adults with chronic respiratory diseases: results of the EVAN-65 study,' are detailed in a study published in Vaccine. According to recent research published in the journal Vaccine, "A prospective cohort study evaluating the clinical effectiveness of the 23-valent pneumococcal polysaccharide vaccine was conducted among 1298 Spanish older adults with chronic respiratory diseases (bronchitis, emphysema or asthma) who were followed between 2002 and 2005. Main outcomes were all-cause community-acquired pneumonia (CAP) and 30 days mortality from CAP." "The association between...
Source: Vaccine Weekly (2008-05-28)
|
